60 http://clinicaloptions.com/oncology.aspx en-us ℗ & © 2006 Clinical Care Options CCO is your best source for the newest oncology treatment data. Clinical Care Options Audio highlights from independent conference coverage and other educational programs Clinical Care Options Oncology vkeane@clinicaloptions.com Clinical Care Options A Treatment Update from Clinical Care Options John L. Marshall, MD, discusses the latest treatment developments in gastrointestinal cancers, focusing on advances in the management of colorectal cancer, including new chemotherapeutic and biologic approaches, and also discussing emerging strategies in hepatocellular carcinoma, gastric and esophageal, and pancreatic cancers. http://clinicaloptions.com/onc_podcast_audio_gitreatment.mp3 Fri, 21 Mar 2008 17:00:00 GMT 56:18 gastrointestinal, cancer, Marshall Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Clifford A. Hudis, MD, highlights key studies including the promise of pharmacogenomics for patients with breast cancer in the metastatic setting. http://clinicaloptions.com/onc_podcast_audio_bc07_hudis.mp3 Wed, 23 Jan 2008 17:00:00 GMT 4:43 oncology, breast cancer, Hudis Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Sagar Lonial, MD, updates maturing clinical trial data in newly diagnosed and relapsed multiple myeloma patients and discusses emerging therapies. http://clinicaloptions.com/onc_podcast_audio_heme07_lonial.mp3 Fri, 18 Jan 2008 17:00:00 GMT 3:19 hematology, Multiple Myeloma, MML, Lonial Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Hagop M. Kantarjian, MD, provides an update on management of acute leukemias, including discussion of prognostic markers, optimal induction and maintenance therapies, and new agents. http://clinicaloptions.com/onc_podcast_audio_heme07_kantarjian.mp3 Tue, 15 Jan 2008 17:00:00 GMT 4:50 hematology, leukemia, Kantarjian Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Daniel F. Hayes, MD, discusses studies that focused on the benefits of tailoring patients to individualized therapy to be able to predict which patients will or will not benefit from chemotherapy or hormonal therapy. http://clinicaloptions.com/onc_podcast_audio_bc07_hayes.mp3 Tue, 8 Jan 2008 17:00:00 GMT 5:32 oncology, breast cancer, Hayes Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Moshe Talpaz, MD, describes the emerging data on the treatment of chronic myelogenous leukemia, with discussion of the use of tyrosine kinase inhibitors as well as response characteristics in this patient population. http://clinicaloptions.com/onc_podcast_audio_heme07_talpaz.mp3 Mon, 7 Jan 2008 17:00:00 GMT 5:42 hematology, chronic myelogenous leukemia, Talpaz Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Edith A. Perez, MD, reviews studies that highlighted molecular profiling in estrogen receptor-positive disease to determine if patients will benefit from chemotherapy. She also comments on the use of targeted therapies in the adjuvant setting. http://clinicaloptions.com/onc_podcast_audio_bc07_perez.mp3 Fri, 4 Jan 2008 17:00:00 GMT 2:52 oncology, breast cancer, Perez Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Peter Ravdin, MD, describes the use of biomarkers and molecular tests and how those will help enhance clinical decisions for treating patients with early breast cancer. He also comments on the use of aromatase inhibitors in patients with early-stage breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc07_ravdin.mp3 Thu, 3 Jan 2008 17:00:00 GMT 9:05 oncology, breast cancer, Ravdin Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Michael J. Keating, MB BS, gives an overview of new insights into the genetics, biology, and immunology of chronic lymphocytic leukemia and new advances in chemoimmunotherapy. http://clinicaloptions.com/onc_podcast_audio_heme07_keating.mp3 Wed, 2 Jan 2008 17:00:00 GMT 6:21 hematology, leukemia, Keating Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Alan F. List, MD, discusses the importance of dosing and scheduling of therapies in myelodysplastic syndrome, as well as the biology of the disease, supportive care and emerging treatments. http://clinicaloptions.com/onc_podcast_audio_heme07_list.mp3 Fri, 28 Dec 2007 17:00:00 GMT 5:08 hematology, myelodysplastic, List Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Julie M. Vose, MD, describes evolving strategies in the treatment of non-Hodgkins lymphoma and the incorporation of newer agents into therapy. http://clinicaloptions.com/onc_podcast_audio_heme07_vose.mp3 Wed, 26 Dec 2007 17:00:00 GMT 5:06 hematology, non-Hodgkin's lymphoma, Vose Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Clifford Hudis, MD, reviews the efficacy and safety data of ongoing clinical trials in both the adjuvant and metastatic breast cancer settings. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_hudis.mp3 Tue, 19 Jun 2007 17:00:00 GMT 11:46 Oncology, Breast Cancer, Hudis Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Everett Vokes, MD, highlights the emergence of new data on HPV and prognosis, the clinical importance of EGFR blockade, and treatment of iodine-refractory thyroid cancer. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_vokes.mp3 Fri, 15 Jun 2007 17:00:00 GMT 3:36 Oncology, HPV, Thyroid Cancer, Vokes Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Nicholas Vogelzang, MD, discusses results from recent clinical trials as well as exciting technological advances in detection and how these may impact patient outcomes for prostate cancer patients. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_vogelzang.mp3 Thu, 14 Jun 2007 17:00:00 GMT 6:03 Oncology, Prostate Cancer, Vogelzang Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Alan P. Venook, MD, describes the most important findings in colorectal cancer, along with highlights from key presentations in pancreatic cancer, esophagogastric adenocarcinoma, and hepatocellular carcinoma. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_venook.mp3 Wed, 13 Jun 2007 17:00:00 GMT 9:47 Oncology, Colorectal Cancer, Venook Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago David Gandara, MD, emphasizes the importance of tumor biology in assessing better treatment choices for patients with SCLC and NSCLC. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_gandara.mp3 Tue, 12 Jun 2007 17:00:00 GMT 2:54 Oncology, Lung Cancer, Gandara Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Nicholas J. Robert, MD, highlights clinical trial data and vaccine therapy in early stage breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc06_targetedagents.mp3 Thu, 18 Jan 2007 17:00:00 GMT 5:15 breast cancer, vaccine, Robert Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Peter Ravdin, MD, PhD, discusses endocrine therapy strategies in the adjuvant setting. http://clinicaloptions.com/onc_podcast_audio_bc06_endocrine.mp3 Thu, 18 Jan 2007 17:00:00 GMT 4:42 breast cancer, adjuvant, Ravdin Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando John C. Byrd, MD, reviews maturing data on treatment of CLL, introduces early data on exciting new therapies in both front-line and relapsed/refractory settings, and discusses tools for better defining prognosis. http://clinicaloptions.com/onc_podcast_audio_heme06_byrd.mp3 Mon, 15 Jan 2007 17:00:00 GMT 4:37 hematology, leukemia, Byrd Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Hope S. Rugo, MD, reviews detection, prevention, and risk stratification data. http://clinicaloptions.com/onc_podcast_audio_bc06_detect.mp3 Fri, 12 Jan 2007 17:00:00 GMT 2:47 breast cancer, detection, Rugo Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Moshe Talpaz, MD, discusses appropriate positioning of therapies and ongoing controversies regarding bone marrow transplant for patients with CML. http://clinicaloptions.com/onc_podcast_audio_heme06_talpaz.mp3 Fri, 5 Jan 2007 17:00:00 GMT 6:02 hematology, CML, Talpaz Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Clifford A. Hudis, MD, discusses emerging targeted therapies in the treatment of metastatic breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc06_metastatic.mp3 Fri, 5 Jan 2007 17:00:00 GMT 6:34 breast cancer, metastatic, Hudis Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Julie M. Vose, MD, updates major clinical trial results in non-Hodgkin's lymphoma and presents emerging data on novel therapies. http://clinicaloptions.com/onc_podcast_audio_heme06_vose.mp3 Tue, 9 Jan 2007 17:00:00 GMT 4:25 hematology, lymphoma, Vose Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Kenneth Anderson, MD, describes the evolving story of myeloma therapy in both front-line and previously treated patients. http://clinicaloptions.com/onc_podcast_audio_heme06_anderson.mp3 Fri, 5 Jan 2007 17:00:00 GMT 5:18 hematology, myeloma, Anderson Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Hagop M. Kantarjian, MD, highlights the impact of new agents that show promise for treatment of acute leukemia and myelodysplastic syndrome. http://clinicaloptions.com/onc_podcast_audio_heme06_kantarjian.mp3 Fri, 5 Jan 2007 17:00:00 GMT 8:39 hematology, leukemia, Kantarjian Clinical Care Options A CCO Oncology Audio Discussion Listen to Harold J. Burstein, MD, PHD, discuss treatment options for postmenopausal women with early-stage hormone receptor-positive breast cancer http://clinicaloptions.com/onc_podcast_audio_tu_postmenopausal.mp3 Wed, 2 Aug 2006 17:00:00 GMT 25:38 oncology, breast cancer, Burstein Clinical Care Options A CCO Oncology Audio Discussion Hope Rugo, MD, discusses treatment options for premenopausal women with early-stage, hormone-receptor positive breast cancer in this CCO Audio Discussion. http://clinicaloptions.com/onc_podcast_audio_tu_premenopausal.mp3 Fri, 21 Jul 2006 17:00:00 GMT 27:36 oncology, breast cancer, Rugo Clinical Care Options Independent highlights from the oncology meeting in Atlanta Kenneth Anderson, MD, discusses new studies in multiple myeloma, including the Plenary presentation on the use of conventional melphalan and prednisone combined with the novel agent thalidomide in patients with newly diagnosed multiple myeloma. http://clinicaloptions.com/onc_podcast_audio_clinonc06_anderson.mp3 Tue, 20 Jun 2006 17:00:00 GMT 5:37 oncology, hematology, myeloma, Anderson Clinical Care Options Independent highlights from the oncology meeting in Atlanta Hagop M. Kantarjian, MD, highlights important new studies in acute myeloid leukemia and chronic myeloid leukemia. http://clinicaloptions.com/onc_podcast_audio_clinonc06_kantarjian.mp3 Wed, 21 Jun 2006 17:00:00 GMT 9:51 oncology, hematology, leukemia, Kantarjian Clinical Care Options Independent highlights from the oncology meeting in Atlanta Corey J. Langer, MD, provides an update on the latest developments in head and neck cancer, including multiple trials describing the efficacy of TPF (docetaxel, cisplatin, 5-FU) as induction therapy in locally advanced disease. http://clinicaloptions.com/onc_podcast_audio_clinonc06_langer.mp3 Mon, 19 Jun 2006 17:00:00 GMT 6:25 oncology, head cancer, neck cancer, Langer Clinical Care Options Independent highlights from the oncology meeting in Atlanta Clifford A. Hudis, MD, highlights prominent clinical trial data that may have practical therapeutic implications in the management of breast cancer patients. http://clinicaloptions.com/onc_podcast_audio_clinonc06_hudis.mp3 Thu, 22 Jun 2006 17:00:00 GMT 4:48 oncology, breast cancer, Hudis Clinical Care Options Independent highlights from the oncology meeting in Atlanta John L. Marshall, MD, talks about the efficacy of aggressive combination chemotherapy in metastatic colorectal cancer, the use of biologic agents, and the identification of patient subsets appropriate for more aggressive therapy. http://clinicaloptions.com/onc_podcast_audio_clinonc06_marshall.mp3 Fri, 16 Jun 2006 17:00:00 GMT 3:04 oncology, colorectal, cancer, Marshall Clinical Care Options Independent highlights from the oncology meeting in Atlanta Alexandra M. Levine, MD, reviews the most important new data on the treatment and management of patients with low-grade and mantle cell non-Hodgkins lymphoma. http://clinicaloptions.com/onc_podcast_audio_clinonc06_levine.mp3 Thu, 15 Jun 2006 17:00:00 GMT 9:47 oncology, hematology, lymphoma, Levine Clinical Care Options Independent highlights from the oncology meeting in Atlanta David R. Gandara, MD, discusses updates on new trial data and biomarker studies and how they may impact clinical practice for the management of lung cancer patients. http://clinicaloptions.com/onc_podcast_audio_clinonc06_gandara.mp3 Wed, 14 Jun 2006 17:00:00 GMT 3:57 oncology, lung cancer, Gandara Clinical Care Options Independent highlights from the oncology meeting in Atlanta Nicholas J. Vogelzang, MD, discusses new data and their clinical implications for the management of prostate cancer patients. http://clinicaloptions.com/onc_podcast_audio_clinonc06_vogelzang.mp3 Tue, 13 Jun 2006 17:00:00 GMT 7:47 oncology, prostate cancer, Vogelzang Clinical Care Options Independent highlights from the hematology meeting in Atlanta Owen O'Connor, MD, summarizes the clinical implications of new data in the setting of lymphoma treatment. http://clinicaloptions.com/onc_podcast_audio_hematology05_oconnor.mp3 Wed, 12 Apr 2006 17:00:00 GMT 6:50 hematology, O'Brien, CML Clinical Care Options Independent highlights from the hematology meeting in Atlanta Stephen O'Brien, MB ChB, PhD, discusses promising new agents in the treatment of CML, as well as new data on imatinib. http://clinicaloptions.com/onc_podcast_audio_hematology05_obrien.mp3 Sun, 09 Apr 2006 17:00:00 GMT 2:05 hematology, O'Brien, CML Clinical Care Options Independent highlights from the hematology meeting in Atlanta Michael J. Keating, MB BS, describes new treatment strategies, and the latest results on prognostic factors for positive outcomes in CLL. http://clinicaloptions.com/onc_podcast_audio_hematology05_keating.mp3 Sun, 19 Mar 2006 17:00:00 GMT 2:44 hematology, Keating, CLL Clinical Care Options Independent highlights from the hematology meeting in Atlanta Dan Douer, MD, highlights the latest data from the meeting in the treatment of acute leukemias and MDS. http://clinicaloptions.com/onc_podcast_audio_hematology05_douer.mp3 Sun, 19 Mar 2006 17:00:00 GMT 4:46 hematology, Douer, leukemia Clinical Care Options Independent highlights from the hematology meeting in Atlanta Kenneth Anderson, MD, reviews key findings on new agents in the management of multiple myeloma presented at the meeting. http://clinicaloptions.com/onc_podcast_audio_hematology05_anderson.mp3 Mon, 6 Mar 2006 17:00:00 GMT 8:34 hematology, Anderson, multiple myeloma Clinical Care Options Independent highlights from the breast cancer meeting in San Antonio Nancy Davidson, MD, reviews key learnings about hormonal, taxane, and trastuzumab therapy from the conference. http://clinicaloptions.com/onc_podcast_audio_sa05_davidson.mp3 Thu, 16 Feb 2006 17:00:00 GMT 2:58 breast cancer, Davidson, taxane Clinical Care Options Independent highlights from the breast cancer meeting in San Antonio Hope S. Rugo, MD, summarizes the clinical implications of new findings on breast cancer biology. http://clinicaloptions.com/onc_podcast_audio_sa05_rugo.mp3 Thu, 16 Feb 2006 17:00:00 GMT 5:37 breast cancer, Rugo, biology Clinical Care Options Independent highlights from the breast cancer meeting in San Antonio Christy Russell, MD, reviews the latest data from clinical trials in the metastatic setting. http://clinicaloptions.com/onc_podcast_audio_sa05_russell.mp3 Thu, 16 Feb 2006 17:00:00 GMT 6:43 breast cancer, Russell, clinical trial Clinical Care Options Independent highlights from the breast cancer meeting in San Antonio Peter Ravdin, MD, PhD, discusses key results from the latest adjuvant trials. http://clinicaloptions.com/onc_podcast_audio_sa05_ravdin.mp3 Thu, 16 Feb 2006 17:00:00 GMT 9:49 breast cancer, Ravdin, adjuvant therapy